SUIVAC PRRS-IN
Pigs
2.0 ml i. m.
Product characteristics
The inactivated vaccine against porcine reproduction and respiratory syndrome (PRRS).
Composition (active substances, excipients)
Each one-immunization dose (2 ml) contains:
Active components:
PRRS inactivated virus:
VD-E1 strain 104.8 up to 106.3 CCID50 prior to inactivation;
VD-E2 strain 103.8 up to 105.3 CCID50 prior to inactivation;
VD-A1 strain 104.8 up to 106.3 CCID50 prior to inactivation.
Excipients:
Thiomersalum NMT 0,2 mg;
Saponinum guillaiae NMT 0,4 mg;
Emulsio olei 0.35 to 0.37 ml;
Medium with immunogen 1.63 to 1.65 ml.
Dosage form and package
Dosage form:
Injections.
Type of package:
Glass or plastic medicine bottle closed with a rubber plug and aluminum torque ring, placed in a carton box. The package also contains package information.
Size of package:
Pharmacotherapeutic group or mode of action:
Veterinaria immunopraeparata.
An inactivated PRRS virus of VD-E1, VD-E2 and VD-A1 strains represents the active ingredient. After parenteral administration of the vaccine, the immune system of the animal being vaccinated is activated which results in an induction of the specific immunity to PRRS. The immunity develops within 3 weeks after re-vaccination and persists for 4 to 6 months.
Indications
SUIVAC PRRS-IN inj. ad us. vet. is an inactivated vaccine designed for immunization of pigs against reproduction and respiratory syndrome of pigs.
Contraindications
Animals with the already developed clinical signs of the disease and animals with fever should not be vaccinated.
Interactions
None are known.
Dosage
An immunization dose is 2 ml.
Route of administration
The vaccine should be administered deep i. m. at an area of the neck behind the ear.
The basic immunization scheme consists in primary vaccination with one subsequent re-vaccination. It is to be recommended two re-vaccinations.
The following immunization schemes may be recommended for the immunization of individual categories of pigs:
Non-immunized gilts:
the primary vaccination at an age of 5 to 6 months (prior to mating) with re-vaccination over 3 to 4 weeks and with a subsequent second re-vaccination over 6 to 4 weeks prior to the expected farrowing.
Piglets:
the primary vaccination at an age of 6 to 10 weeks and re-vaccination over 3 to 4 weeks and the subsequent re-vaccination over further 3 to 4 weeks.
The above-mentioned immunization schemes are only of an orientation character. The scope of immunization is at discretion of the veterinary doctor, and depends also on a particular epizootological situation.
Adverse reactions
After vaccination, a moderate general reaction may occur manifesting itself by feebleness, inappetence and sometimes also increased body temperature.
At the site of administration, a transient moderate local reaction may occur. These reactions subside.
The product must be used before expiration of the shelf life indicated on the label of each medicinal bottle, i.e. within 18 months. The medicinal bottle with the vaccine must be used within 10 hours after it has been opened.
Warning
Prior to use, the vaccine should be allowed to reach the ambient temperature. Shake the vaccine well before use.
Pregnancy and lactation
The vaccine is designed for pregnant sows, however not later than 14 days prior to expected farrowing. In the course of lactation, sows should not be immunized.
Storage
In a dry and dark place at temperatures between 2 and 8 °C, prevent from freezing!
2.0 ml i. m.
Product characteristics
The inactivated vaccine against porcine reproduction and respiratory syndrome (PRRS).
Composition (active substances, excipients)
Each one-immunization dose (2 ml) contains:
Active components:
PRRS inactivated virus:
VD-E1 strain 104.8 up to 106.3 CCID50 prior to inactivation;
VD-E2 strain 103.8 up to 105.3 CCID50 prior to inactivation;
VD-A1 strain 104.8 up to 106.3 CCID50 prior to inactivation.
Excipients:
Thiomersalum NMT 0,2 mg;
Saponinum guillaiae NMT 0,4 mg;
Emulsio olei 0.35 to 0.37 ml;
Medium with immunogen 1.63 to 1.65 ml.
Dosage form and package
Dosage form:
Injections.
Type of package:
Glass or plastic medicine bottle closed with a rubber plug and aluminum torque ring, placed in a carton box. The package also contains package information.
Size of package:
- 1 x 25 doses, i.e. 1 x 50 ml in a medical bottle with the effective volume of 50 ml;
- 1 x 50 doses, i.e. 1 x 100 ml in a medical bottle with the effective volume of 100 ml;
- 1 x 250 doses, i.e. 1 x 500 ml in a medical bottle with the effective volume of 500 ml.
Pharmacotherapeutic group or mode of action:
Veterinaria immunopraeparata.
An inactivated PRRS virus of VD-E1, VD-E2 and VD-A1 strains represents the active ingredient. After parenteral administration of the vaccine, the immune system of the animal being vaccinated is activated which results in an induction of the specific immunity to PRRS. The immunity develops within 3 weeks after re-vaccination and persists for 4 to 6 months.
Indications
SUIVAC PRRS-IN inj. ad us. vet. is an inactivated vaccine designed for immunization of pigs against reproduction and respiratory syndrome of pigs.
Contraindications
Animals with the already developed clinical signs of the disease and animals with fever should not be vaccinated.
Interactions
None are known.
Dosage
An immunization dose is 2 ml.
Route of administration
The vaccine should be administered deep i. m. at an area of the neck behind the ear.
The basic immunization scheme consists in primary vaccination with one subsequent re-vaccination. It is to be recommended two re-vaccinations.
The following immunization schemes may be recommended for the immunization of individual categories of pigs:
Non-immunized gilts:
the primary vaccination at an age of 5 to 6 months (prior to mating) with re-vaccination over 3 to 4 weeks and with a subsequent second re-vaccination over 6 to 4 weeks prior to the expected farrowing.
- Immunized gilts:
- Immunized sows:
Piglets:
the primary vaccination at an age of 6 to 10 weeks and re-vaccination over 3 to 4 weeks and the subsequent re-vaccination over further 3 to 4 weeks.
- Non-immunized boars:
- Immunized boars:
The above-mentioned immunization schemes are only of an orientation character. The scope of immunization is at discretion of the veterinary doctor, and depends also on a particular epizootological situation.
Adverse reactions
After vaccination, a moderate general reaction may occur manifesting itself by feebleness, inappetence and sometimes also increased body temperature.
At the site of administration, a transient moderate local reaction may occur. These reactions subside.
The product must be used before expiration of the shelf life indicated on the label of each medicinal bottle, i.e. within 18 months. The medicinal bottle with the vaccine must be used within 10 hours after it has been opened.
Warning
Prior to use, the vaccine should be allowed to reach the ambient temperature. Shake the vaccine well before use.
Pregnancy and lactation
The vaccine is designed for pregnant sows, however not later than 14 days prior to expected farrowing. In the course of lactation, sows should not be immunized.
Storage
In a dry and dark place at temperatures between 2 and 8 °C, prevent from freezing!
